Literature DB >> 23991970

Biomarkers screening between preoperative and postoperative patients in pancreatic cancer.

Pei Li1, Juan Yang, Qing-Yong Ma, Zheng Wu, Chen Huang, Xu-Qi Li, Zheng Wang.   

Abstract

OBJECTIVE: To investigate discriminating protein patterns and potential biomarkers in serum samples between pre/postoperative pancreatic cancer patients and healthy controls.
METHODS: 23 serum samples from PC patients (12 preoperative and 11 postoperative) and 76 from healthy controls were analyzed using matrix-assisted laser desorption and ionization time-of-flight mass spectrometry (MALDI-TOF MS) technique combined with magnetic beads-based weak cation-exchange chromatography (MB-WCX). ClinProTools software selected several markers that made a distinction between pancreatic cancer patients and healthy controls.
RESULTS: 49 m/z distinctive peaks were found among the three groups, of which 33 significant peaks with a P < 0.001 were detected. Two proteins could distinguish the preoperative pancreatic cancer patients from the healthy controls. About 15 proteins may be potential biomarkers in assessment of pancreatic cancer resection.
CONCLUSION: MB-MALDI-TOF-MS method could generate serum peptidome profiles of pancreatic cancer and provide a new approach to identify potential biomarkers for diagnosis and prognosis of this malignancy.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23991970     DOI: 10.7314/apjcp.2013.14.7.4161

Source DB:  PubMed          Journal:  Asian Pac J Cancer Prev        ISSN: 1513-7368


  2 in total

1.  Identification of peptide regions of SERPINA1 and ENOSF1 and their protein expression as potential serum biomarkers for gastric cancer.

Authors:  Juan Yang; Xiaofan Xiong; Xiaofei Wang; Bo Guo; Kang He; Chen Huang
Journal:  Tumour Biol       Date:  2015-02-14

2.  Differential peptidomics assessment of strain and age differences in mice in response to acute cocaine administration.

Authors:  Elena V Romanova; Stanislav S Rubakhin; John R Ossyra; Jonathan A Zombeck; Michael R Nosek; Jonathan V Sweedler; Justin S Rhodes
Journal:  J Neurochem       Date:  2015-08-25       Impact factor: 5.372

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.